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The development of the mature insect trachea requires a complex series of cellular events, including tracheal
cell specification, cell migration, tubule branching, and tubule fusion. Here we describe the identification of the
Drosophila melanogaster dysfusion gene, which encodes a novel basic helix-loop-helix (bHLH)–PAS protein
conserved between Caenorhabditis elegans, insects, and humans, and controls tracheal fusion events. The
Dysfusion protein functions as a heterodimer with the Tango bHLH-PAS protein in vivo to form a putative
DNA-binding complex. The dysfusion gene is expressed in a variety of embryonic cell types, including tracheal-
fusion, leading-edge, foregut atrium cells, nervous system, hindgut, and anal pad cells. RNAi experiments
indicate that dysfusion is required for dorsal branch, lateral trunk, and ganglionic branch fusion but not for
fusion of the dorsal trunk. The escargot gene, which is also expressed in fusion cells and is required for tracheal
fusion, precedes dysfusion expression. Analysis of escargot mutants indicates a complex pattern of dysfusion
regulation, such that dysfusion expression is dependent on escargot in the dorsal and ganglionic branches but
not the dorsal trunk. Early in tracheal development, the Trachealess bHLH-PAS protein is present at
uniformly high levels in all tracheal cells, but since the levels of Dysfusion rise in wild-type fusion cells, the
levels of Trachealess in fusion cells decline. The downregulation of Trachealess is dependent on dysfusion
function. These results suggest the possibility that competitive interactions between basic helix-loop-helix–PAS
proteins (Dysfusion, Trachealess, and possibly Similar) may be important for the proper development of the
trachea.
The insect tracheal system consists of an intricately branched
system of tubules that provide oxygen throughout the animal.
The formation of the trachea consists of a series of develop-
mental events, and its analysis provides an excellent model
system for studying the morphogenesis of other branched
structures, such as the vertebrate lung airways, circulatory sys-
tem, kidney ducts, and excretory epithelia (9, 27, 38). The
trachea is derived from an array of segmentally repeated clus-
ters of precursor cells. After the tracheal precursor cells divide
and invaginate, they extend branches, and the branches from
neighboring segments fuse to form the mature tracheal tree.
The fusion process is mediated by a distinct fusion cell residing
on each branch (41). Branching and fusion are complex cellu-
lar processes and pose a number of developmental questions.
How are fusion cells specified during tracheal development?
What are the short-range and long-range factors that guide
tracheal branches to their fusion partners? What is the nature
of the adhesive and contact-guidance interactions that mediate
fusion and allow the formation of adherens junctions that seal
intercellular junctions? How is the cytoskeleton rearranged to
allow the tracheal lumen to extend throughout the branch?
The tracheal primordia extend branches in six directions
under the guidance of the branchless gene (44). All of these
branches except the visceral branch will fuse with tracheal
branches derived from other primordia. The dorsal trunk is
formed by fusion of anterior and posterior branches from ad-
jacent segments, as is the lateral trunk, which is formed by
fusion of lateral trunk anterior and posterior branches. The
dorsal branches travel over the dorsal side of the embryo and
fuse along the dorsal midline to their partner from the identi-
cal hemisegment. The ganglionic branches migrate ventrally
and join at the ventral midline, although only the three ante-
riormost branches fuse. There is a single fusion cell for each
branch, and the fusion cells are characterized by patterns of
gene expression distinct from other tracheal cells (41). The
Escargot (Esg) zinc finger transcription factor is prominently
expressed during tracheal development in fusion cells and no
other tracheal cell (41, 42, 46). esg mutants show fusion cell
defects in the lateral trunk, dorsal branch, and ganglionic
branch, but dorsal trunk fusion is relatively normal. Examina-
tion of esg mutants indicates that expression of several, but not
all, fusion cell-specific genes and markers is absent in the
dorsal branch and the ganglionic branch (42), and there is an
excess of branching and gene expression associated with
branching. In addition, esg is required for DE-cadherin expres-
sion and the ability of fusion cells to form adhesive contacts
and adherens junctions (46). The loss of esg in lateral trunk is
the most extreme, resulting in death of the fusion cells. Impor-
tant issues regarding the tracheal function of esg deal with the
identity of genes regulated by esg and why esg is required for
tracheal fusion in some branches but not others.
Three proteins that function prominently in tracheal devel-
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opment are the Trachealess (Trh), Similar (Sima), and Tango
(Tgo) basic helix-loop-helix (bHLH)–PAS proteins. Trh and
Tgo form a heterodimer that controls transcription and initial
formation of the tracheal primordia along with the Drifter
(Dfr) POU-homeobox coactivator (4, 16, 32, 43, 50). Sima and
Tgo form a protein dimer that controls the transcriptional
response to hypoxia (22, 29). Since low cellular oxygen condi-
tions induce additional tracheal branching (18), Sima may au-
tonomously or nonautonomously be required for terminal tra-
cheal branching. Tgo is found in all embryonic cells. In the
absence of a bHLH-PAS partner protein, Tgo is found in the
cytoplasm, but in the presence of a partner protein, they dimer-
ize, translocate into the nucleus, bind DNA, and activate tran-
scription (49). Since there may exist multiple bHLH-PAS part-
ners of Tgo in the same cell, it has been proposed that the
function and levels of bHLH-PAS proteins may be regulated
by competitive interactions (13, 52). In part for this reason, it
is important to identify all Drosophila melanogaster bHLH-PAS
proteins and determine where they are expressed.
In the present study, we describe a novel bHLH-PAS gene,
dysfusion (dys), which is expressed in all tracheal fusion cells, as
well as the epidermal leading edge cells and several other cell
types. The dys gene is a member of a discrete subfamily of
bHLH-PAS proteins conserved between nematodes, insects,
and mammals. Tgo accumulates in nuclei of dys-expressing
cells, suggesting that it is a partner of Dys in vivo. dys-RNAi
experiments reveal tracheal fusion defects in the lateral trunk,
dorsal branch, and ganglionic branch but not in the dorsal
trunk. The esg gene is expressed in all fusion cells before dys,
and esg expression is normal in dys RNAi-injected embryos.
However, esg mutant embryos show an absence of dys expres-
sion in tracheal fusion cells in most branches, but not the
dorsal trunk, further indicating branch-specific function of esg.
The appearance of Dys in tracheal fusion cells coincides with a
steep drop in Trh levels in fusion cells, and this reduction is dys
dependent. This indicates that one function of dys in tracheal
fusion cell development is to downregulate Trh protein levels.
This provides the first in vivo evidence that bHLH-PAS pro-
teins regulate levels of other bHLH-PAS proteins during de-
velopment and possibly influence cell fate and morphogenetic
decisions.
MATERIALS AND METHODS
Drosophila strains. Drosophila strains utilized include esg05730 (lethal P[lacZ]
insertion in esg), esgG66 (null P[esg-lacZ] mutation), Df(2L)osp29 (esg deficiency),
pucA251.1F3 (P[lacZ] insertion in puckered), trh1 (severe mutation), and
Df(3R)Espl3 (deficiency [96F1; 97B1] that removes dys). Homozygous mutant
embryos were identified by balancing mutations over either CyO Krüppel-Gal4
UAS-GFP, TM3 Krüppel-Gal4 UAS-GFP, or CyO P[ftz-lacZ] (5), and selecting
for embryos without GFP or ftz-lacZ expression.
Identification of dys gene and mRNA structure. The human hypoxia-inducible
factor 1 (HIF-1) PAS-1 region was screened versus Drosophila genomic se-
quence data (1) by using tBLASTN (2), and a novel bHLH-PAS-containing gene
was identified at 96F on the third chromosome. Drosophila dys cDNA was cloned
by using an reverse transcription-PCR (RT-PCR) strategy based on the genomic
sequence. Initially, four pairs of primers predicted to be in dys coding sequences
were utilized: (i) exons 2 and 3, S1 (ACGTGCGATCGACGATATGT) and A1
(CGCATTTATGAGATCGCGTC); (ii) exons 3 to 6, S2 (GATGCAAACAAA
TCGACGAA) and A2 (ATCGTAAACGGAGTCACCGT); (iii) exons 5 to 8, S3
(GCTTCTTGATGATGCTCACA) and A3 (TTGCGCCTCCGTCAGATTAT);
and (iv) exons 8 to 10, S4 (ATAATCTGACGGAGGCGCAA) and A4 (TCTG
GCTTAAGTGCTGCGAA). Total RNA from an overnight collection of Dro-
sophila embryos was extracted by using an RNeasy Mini Kit (Qiagen). Poly(A)
mRNA was extracted from total RNA by using Oligotex (Qiagen). First-strand
cDNA was synthesized by using SuperScript reverse transcriptase (Gibco-BRL)
and used as a template for PCRs. PCR amplification of primer pairs 1 to 4
resulted in the generation of dys cDNA fragments of 515, 388, 665, and 1,141 bp.
The amplified fragments were cloned into pCR2.1-TOPO (Invitrogen) and se-
quenced at the UNC Automated Sequencing Facility.
5-RACE. The 5-most dys sequences were obtained by performing 5 RACE
(rapid amplification of cDNA ends) with a SMART RACE cDNA amplification
kit (BD Biosciences). First-strand cDNA was synthesized from poly(A) RNA at
42°C for 1 h with PowerScript reverse transcriptase by using dys internal primer
A3 (TTGCGCCTCCGTCAGATTAT). The SMART II A oligonucleotide (AA
GCAGTGGTATCAACGCAGAGTACGCGGG) was included. This oligonu-
cleotide anneals to the C-rich cDNA 3 tail and serves as a primer for second-
strand DNA synthesis. Primer S5 (TCGTCTGCGGCTGCTGCTGTTGC),
derived from the dys sequence, was used to perform PCRs for 5 RACE, along
with a universal primer (CTAATACGACTCACTATAGGGCAAGCAGTGGT
ATCAACGCAGAGT) that can anneal to the SMART II A oligonucleotide
sequence. The amplified fragments were cloned and sequenced.
3 RACE. The 3-most dys sequences were obtained by performing 3 RACE
with a SMART RACE cDNA amplification kit. First-strand cDNA was synthe-
sized from poly(A) RNA at 42°C for 1 h with reverse transcriptase by using the
oligo(dT)-based 3-RACE CDS primer A [AAGCAGTGGTATCAACGCAGA
GTAC(T)30N1N, where N is A, C, G, or T and N1 is A, C, or G]. The 3
RACE forward primer (GATGTCAGATCCTTTGGTACCGGTCACGTA)
was derived from the dys sequence and used in PCRs along with the universal
primer that can anneal to primer A. All amplified fragments were cloned and
sequenced.
Sequence comparisons and phylogenetic analysis. The Dys bHLH sequence
was aligned to bHLH sequences from representatives of all subfamilies of
bHLH-PAS proteins by using CLUSTALX (48). The alignment was then used to
create a phylogenetic tree by using the neighbor-joining method (40) and
PAUP*4.0 software (45). Clades were assessed by bootstrap analysis of 1,000
repetitions. The tree was visualized with TreeView (33). The Dys sequence from
Anopheles gambiae was determined by searching the Anopheles genome sequence
(15) for Dys-related sequences. Significant homology was observed for all exons
except exons 1, 2, and 4. The Caenorhabditis elegans cDNA clone sequence of
C15C8.2 was provided by JoAnne Powell-Coffman (Iowa State University), and
the human NXF (H-NXF) sequence was provided by Cam Patterson (University
of North Carolina at Chapel Hill).
Dys antibody production. Polyclonal antibodies against Dys were generated by
using a Dys fusion protein containing an N-terminal His6 tag. A dys cDNA
fragment corresponding to amino acids (aa) 584 to 803 was cloned into the XhoI
site of pET-15b (Novagen). After transformation into Escherichia coli
BL21(DE3), cells were grown and His-Dys fusion protein synthesis induced by
the addition of IPTG (isopropyl--D-thiogalactopyranoside). Inclusion bodies
were prepared, solubilized in 10% sodium dodecyl sulfate (SDS), dialyzed in
0.05% SDS–1 mM phenylmethylsulfonyl fluoride–1 phosphate-buffered saline,
and purified by using Talon metal affinity resins (Clontech). The eluted His-Dys
protein was then dialyzed in 0.01% SDS–1 phosphate-buffered saline. Two rats
and two rabbits were immunized by subcutaneous injection of protein (Pocono
Rabbit Farm & Laboratory).
Drosophila immunostaining. Whole-mount embryos were immunostained as
described previously (34). The following primary antibodies and dilutions were
used for immunostaining: rat anti-Dys (1:200), rabbit anti-Dys at 1:800, mouse
monoclonal antibody (MAb) 2A12 at 1:10 (24), MAb anti-Tgo at 1:1 (49), MAb
anti--galactosidase (anti--Gal) (Promega) at 1:1,000, rabbit anti--Gal (Cap-
pell) at 1:2,000, and rat anti-Trh at 1:200 (49). The following secondary antibod-
ies were used: fluorescein isothiocyanate-labeled anti-mouse and anti-rat immu-
noglobulin G (IgG; Molecular Probes), Texas red-labeled anti-rabbit and anti-
mouse IgG (Jackson Laboratories), Alexafluor 594-labeled anti-mouse IgM,
Cy5-labeled anti-mouse IgG (Molecular Probes), alkaline phosphatase (AP)-
labeled anti-rat IgG and IgM, and biotin-SP-labeled anti-mouse IgG (Jackson
Laboratories) used with streptavidin-horseradish peroxidase. All secondary an-
tibodies were used at 1:200 except for Alexafluor 594-labeled anti-mouse IgM,
which was used at 1:1,000. Nonfluorescence staining was developed by using
either AP color development buffer (Bio-Rad) or diaminobenzidine with horse-
radish peroxidase. Photomicrographs were taken with either Zeiss LSM-510
confocal or Axiophot microscopes.
Drosophila in situ hybridization. Drosophila whole-mount embryos were hy-
bridized in situ to a Drosophila dys antisense RNA probe. The probe was 1.1 kb
and was generated by PCR amplification of a dys cDNA clone. The primers A4
and S4 were used, and the region amplified included exons 8 to 10. The PCR
product was cloned into PCRII-TOPO, and a digoxigenin (DIG)-labeled RNA
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probe was synthesized by using SP6 RNA polymerase (Promega) at 37°C for 2 h.
The probe was added to the hybridization buffer (50% deionized formamide; 5
SSC [1 SSC is 0.15 M NaCl plus 0.015 M sodium citrate]; 100 g of sonicated,
denatured salmon sperm DNA/ml; 100 g of E. coli tRNA/ml; 50 g of heparin/
ml; 0.1% Tween 20; pH 4.5). Hybridization was carried out for 16 h at 70°C.
After a washing step, the presence of dys mRNA was detected by incubating
embryos with AP-conjugated anti-DIG antibody (1:1,000) and reaction with
nitroblue tetrazolium plus X-phosphate. Embryos were mounted in 70% glycerol
and examined under bright-field optics.
RNAi. Double-stranded RNA (dsRNA) for RNA interference (RNAi) exper-
iments was prepared for dys and for green fluorescent protein (GFP) by using
modifications of existing protocols (20, 28). The GFP-dsRNA acted as a negative
control. The templates used for synthesis of dsRNA were the products of two-
step PCR. The first step amplified a fragment of cDNA that contains a partial T7
RNA polymerase promoter site. The second PCR step amplified the fragment
and completed the addition of a T7 RNA polymerase site adjacent to both ends
of the cDNA sequence. The first PCR used to amplify dys cDNA utilized the
following primer pair: 5-CGACTCACTATAGGGCGACTCCACGCAACAA
CCTG-3 and 5-CGACTCACTATAGGGTCTGGCTTAAGTGCTGCGAA-3
(the T7 sequences are underlined). This fragment includes 1,027 bp (residues
1399 to 2426; exons 6 to 10) of the dys sequence. The GFP-dsRNA template was
generated by amplifying a 729-bp fragment of pNEGFPX.1 that contains the
GFP gene. The primer pair used was 5-CGACTCACTATAGGGATGGTGA
GCAAGGGCGAGGAG-3 and 5-CGACTCACTATAGGGGTACAGCTCG
TCCATGCCGAG-3. The second step of the PCR used the T7 promoter se-
quence (ATAGAATTCTCTAGAAGCTTAATACGACTCACTATAGGG) as
a primer. This resulted in an amplified fragment with T7 RNA polymerase sites
at both ends, allowing the simultaneous synthesis of sense and antisense RNA.
DNA templates were purified by using QIAquick PCR purification kit (Qiagen).
dsRNAs were synthesized by using T7 RNA polymerase and DNA templates
were removed with RNase-free DNase. After phenol-chloroform extraction and
ethanol precipitation, the dsRNAs were dissolved in Tris-EDTA (TE) at a final
concentration of 5 M. Analysis of dsRNAs by agarose gel electrophoresis
indicated that bands of the expected sizes were present.
Injection needles were baked to remove RNase for injection. Embryos from
w1118 or esg05730 flies were collected over a 60-min period at 25°C and attached
to a coverslip with double-stick tape. They were covered in no. 700 halocarbon oil
and dsRNA solution injected into the ventral and/or posterior side of the embryo
along ca. 30 to 50% of the egg length by using a Picospritzer III Picopump. The
injected embryos were incubated at 18°C for 26 h and at stages 15 and 16 were
collected, dechorionated, fixed, devitellinized, and immunostained. Other em-
bryos were allowed to hatch into first-instar larvae and then transferred to vials.
After further incubation at 25°C, the tracheal phenotypes of second-instar larvae
were examined by bright-field microscopy.
dys viability assays. dys-dsRNA and GFP-dsRNA-injected larvae were trans-
ferred to vials with fly food at a density of 40 larvae/vial and then incubated at
25°C. The number of pupae and emerging adults were counted for each vial.
RESULTS
Identification and sequence of the Drosophila dys gene.
Bioinformatic searches for additional Drosophila bHLH-PAS
genes utilized bHLH and PAS sequences screened against the
genomic sequence generated by the Celera/Berkeley Drosoph-
ila Genome Project (BDGP) (1). When a human HIF-1
PAS-1 region was screened against Drosophila genomic DNA
by using the tBLASTN algorithm (3), a novel bHLH-PAS gene
was identified in the BAC clones BACR13F13 and BACR08G22,
which map to a cytological position, 96F-97A, on chromosome
3. Later, the gene was also identified by the BDGP-Celera
Consortium by using the Genie algorithm (37) and in global
searches for bHLH genes (23, 35). Genie initially predicted
four distinct genes in the region, three of which contain mul-
tiple predicted exons: CG14554 (one exon), CG12561 (three
exons), CG14553 (three exons), and CG14552 (four exons).
Using RT-PCR and DNA sequence analysis, we showed that
these four predicted genes all constitute a single gene, dys, now
referred to as CG32474 (Fig. 1A). dys maps to 96F9-10 accord-
ing to FlyBase (11).
Preliminary experiments indicated that dys is a rare embry-
onic mRNA, an observation consistent with its absence from
the BDGP embryonic expressed sequence tag (EST) collection
of 8,809 distinct mRNAs. RNA was isolated from Drosophila
embryos, and RT-PCR was carried out with primers designed
from genomic sequences. The 5 and 3 ends of the mRNA
were identified by RACE. These experiments provide the se-
quence of the dys mRNA. The genomic sequence comprises 10
exons and spans 21,697 bp (Fig. 1A). The 5-untranslated re-
gion (UTR) determined by RACE is predicted to be 521 nu-
cleotides (nt), and the 3-UTR is 500 nt. Of particular interest,
the 3-UTR of dys, which resides in exon 10, overlaps by 475 bp
the sequence of EST LP05454 (39), which is transcribed in the
other direction (Fig. 1A).
The coding sequence of dys (Fig. 1B) shows a clear relation-
ship to other bHLH-PAS proteins (8, 47). It has a bHLH
domain near the N terminus, followed by PAS-1 and PAS-2
domains. The C-terminal regions of bHLH-PAS proteins gen-
erally contain transcriptional activation domains (see, for ex-
ample, reference 12), although the protein sequences are
poorly conserved. Consistent with that observation, the C-
terminal region of Dys shows little homology with other pro-
teins but contains histidine-rich and proline-rich regions simi-
lar to the C terminus of other bHLH-PAS proteins (8). The
region N terminal to the bHLH domain encoded by exons 1
and 2 is 152 aa, which is uncharacteristically long for bHLH-
PAS proteins. This region contains a large number of glu-
tamine residues, suggesting that at it may act as an N-terminal
transcriptional activation domain. There is also an unusually
long spacer region in the PAS-1 domain that contains a large
number of serines and repeats of Gly-Gly-Ala. The length of
the predicted protein is 918 aa with a predicted molecular mass
of 102 kDa.
Dys-related proteins constitute a discrete subset of evolu-
tionarily conserved bHLH-PAS proteins. Sequence compari-
sons of all existing bHLH-PAS proteins to Dys reveal that it is
a member of a discrete subfamily of bHLH-PAS proteins (Fig.
1C and 2). The complete sequences of representative bHLH-
PAS proteins were compared by CLUSTALX and displayed by
a phylogenetic tree generated by the neighbor-joining method
algorithm (40). C. elegans C15C8.2 (7) (J. Powell-Coffman,
unpublished data), Drosophila Dys (D-Dys), A. gambiae Dys
(An-Dys) (15), and H-NXF (6, 30) (C. Patterson, unpublished
data) cluster as a discrete branch of the phylogenetic tree
consisting of representative bHLH-PAS proteins (Fig. 2). This
result indicates that a dys ancestral gene existed before the
divergence of nematodes, insects, and vertebrates. Quantita-
tively, the bHLH region of D-Dys shows the following percent
identities to the other Dys subfamily proteins: An-Dys (96%),
H-NXF (58%), and C15C8.2 (57%) (Fig. 1C). The percent
identity was only 30% within the bHLH region to the next
closest bHLH-PAS protein, Drosophila Spineless (Ss). Similar
relationships were observed by comparing PAS-1 domains and
PAS-2 domains, although the percent identity was less than for
the bHLH region, as generally observed with bHLH-PAS pro-
tein comparisons. The PAS-1 domain of Dys is characterized
by a long insertion containing a number of Gly-Gly-Ala re-
peats. This insertion is absent in C15C8.2 and H-NXF, but
VOL. 23, 2003 DROSOPHILA dysfusion GENE CONTROLS TRACHEAL FUSION 5627
An-Dys has an even larger insertion with a different sequence
content consisting of stretches of His, Ser, and Gly. In contrast,
the PAS-2 domain is similar in length and colinear between the
subfamily members. Sequences N-terminal to the bHLH do-
main, the spacer between bHLH and PAS-1 domains, and the
regions C-terminal to the PAS-2 domain are poorly conserved
among subfamily members, whereas the spacer between PAS-1
and PAS-2 shows significant sequence identity.
dys is expressed in diverse embryonic cell types. Antisera
were prepared against bacterially synthesized Dys protein de-
rived from the unconserved C-terminal region of the protein,
and whole-mount embryos were immunostained. Dys protein
was found in a number of embryonic cell types (Fig. 3A to C),
and these sites of expression were identical to those observed
for dys RNA, as determined by dys in situ hybridization (Fig.
3D and E) (32). The specificity of Dys antisera was further
FIG. 1. The Drosophila dys gene encodes a bHLH-PAS protein. (A) The sequence structure of the Drosophila dys gene was determined by
comparing the genomic sequence derived from the Celera/BDGP sequence data with cDNA sequence derived by RT-PCR of embryonic RNA.
The dys gene consists of 10 exons, shown as blocks numbered 1 to 10. Filled blocks indicate coding sequence and unfilled blocks the 5-UTR and
3-UTR. The direction of transcription is shown by the arrow following “dysfusion.” The scale bar is shown below the schematic. The EST LP05454
is transcribed in the opposite direction (arrow) and spans 1,560 bp. The 3 end of LP05454 overlaps exon 10 by 475 bp. (B) The conceptual protein
sequence of Drosophila dys is shown with the one-letter amino acid code. The bHLH, PAS-1, and PAS-2 domains are indicated above the sequence.
The extent of the domains was determined by comparison of these proteins to existing bHLH-PAS proteins by using the PAS domain definitions
of Taylor and Zhulin (47). The length of the protein is 918 aa, and numbering is shown to the left of the sequence. The protein region used to
generate Dys antisera spans aa 615 to 834 and is indicated above the sequence (Dys antigen). (C) The bHLH domains of Dys subfamily proteins
were aligned, and the alignment shows the high degree of identity between D. melanogaster Dys (D-Dys), A. gambiae Dys (An-Dys), C. elegans
C15C8.2 (Ce-C15C8.2), and H-NXF. Identities are indicated by a symbol (F), and nonidentities are indicated by the appropriate amino acid
residue. The residue numbering is shown to the left of each sequence.
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demonstrated by immunostaining embryos derived from Df
(3R)Espl3 flies (Fig. 3F). The breakpoints of the Df(3R)Espl3
deficiency are 96F1 and 97B1 and are predicted to delete the
dys gene, which resides at 96F9-10. Embryos homozygous mu-
tant for Df(3R)Espl3 showed no staining with the Dys antisera.
Additionally, in experiments described below (see Fig. 8 and
9), injection of dys RNAi into embryos abolished Dys immu-
noreactivity. The absence of Dys from the mutant embryos was
not due completely to the loss of cells that are Dys positive in
wild-type embryos, since the use of appropriate markers indi-
cated their presence (Fig. 9). These experiments indicate that
the Dys antisera specifically recognizes Dys protein.
Staining with Dys antisera is highly restricted temporally and
spatially. Little, if any, expression is observed before stage 12,
but at stage 12 expression begins in many of the Dys-positive
embryonic cell types. At stage 14, Dys protein is observed in (i)
precursors to the foregut atrium, (ii) a subset of nervous sys-
tem cells that are either part of the medial brain or the frontal
ganglion, (iii) four rows of tracheal fusion cells, (iv) cells at the
position of the epidermal leading edge, (v) the hindgut, and
FIG. 2. Dys belongs to a distinct subfamily of bHLH-PAS proteins. Representatives of all families of bHLH-PAS proteins were compared by
using the bHLH domain protein sequences and aligned by using CLUSTALX. The alignment is represented by a phylogram generated by using
the neighbor-joining method. The tree demonstrates that DroDys, AnoDys, CeC15C8.2, and H-NXF (HumNXF) represent a distinct, evolution-
arily conserved subfamily of bHLH-PAS proteins (bracket). The scale represents the fraction of nonidentical amino acids residues along each
branch. Numbers along each branch are the bootstrap confidence limits with 1,000 repetitions. The identities of the other proteins can be found
in Taylor and Zhulin (47). The species designation precedes each protein acronym (Ano, A. gambiae; Ce, C. elegans; Dro, Drosophila; Mur, murine;
Hum, human).
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(vi) the anal pad (Fig. 3A to C). The frontal ganglion consists
of cells of the stomagastric nervous system located between the
brain and roof of the pharynx (14). Expression remains in all of
these cell types through the remainder of embryonic develop-
ment. All Dys-positive cells showed nuclear localization (Fig. 4
to 6). The leading-edge and tracheal cells are conclusively
identified in the present study, and more-detailed analyses of
the other Dys-positive cells will be provided elsewhere.
dys is expressed in the leading edge. During the process of
dorsal closure, the dorsalmost rows of cells on each side are
referred to as the leading edge. These cells (i) are required for
the process of dorsal closure, (ii) respond to cellular signals
regulating closure, and (iii) form the dorsal zipper after closure
(21). These cells are characterized by changes in cell shape
during the closure process (17), and they interdigitate and
adhere to each other after meeting at the dorsal midline. dys
was examined for expression in the leading-edge cells by ex-
amining for colocalization with Puckered (Puc). The puc gene
is expressed in the leading edge, and pucA251.1F3, an enhancer
trap line with a P[lacZ] insertion in the puc gene expresses lacZ
in the leading edge cells (25). Double staining embryos with
anti-Dys and anti--Gal revealed colocalization of the two
proteins (Fig. 4).
dys is expressed in tracheal fusion cells. Dys protein was
observed in four distinct longitudinal, segmentally repeated
sets of cells along the ectoderm (Fig. 3A to C). The locations
of these cells resembles the pattern of genes expressed exclu-
sively in tracheal fusion cells (41). Embryos were double
stained with MAb 2A12, which stains the tracheal lumen, and
anti-Dys to determine the relationship between Dys-positive
cells and the trachea (Fig. 5). Before fusion, each branch con-
tained a single Dys-positive cell, whereas after fusion there
were two Dys-positive cells at the fusion site of each branch.
This was observed at all sites of tracheal fusion, including the
dorsal trunk, lateral trunk, dorsal branch, and ganglionic
branch, but in no other tracheal cells. Only the three most
anterior (G0, G1, and G2) of the 10 ganglionic branches fuse
at the ventral midline. These three branches possess Dys-pos-
itive cells, but the others do not. Confirmation that the Dys-
positive cells are tracheal fusion cells was shown by double
staining an escargot-lacZ (esg-lacZ) enhancer trap line with
anti--Gal and anti-Dys (Fig. 6). Colocalization was observed
in all Esg-positive tracheal fusion cells.
dys expression precedes tracheal fusion. Time course exper-
iments were carried-out by double staining P[esg-lacZ] em-
bryos with anti-Dys, anti--Gal, and anti-Trh. Anti-Trh stain-
FIG. 3. The dys gene is expressed in multiple cell types. Dys localization was analyzed by immunostaining whole-mount embryos with -Dys
antisera, followed by AP histochemistry. Visualization is by Nomarski optics. (A to C) The embryo is at stage 14; anterior is to the left. (A) Dorsal
view. Dys protein is present in anterior cells corresponding to foregut atrial precursors (arrowhead A), nervous system cells in part of either the
medial brain or the frontal ganglion (arrowhead NS), the leading edge of the dorsal epidermis (arrowhead LE), tracheal fusion cells of the dorsal
branch (arrowhead DB), hindgut (arrowhead HG), and anal pad (arrowhead AP). (B) Sagittal view illustrating tracheal fusion cell staining of
dorsal branch (arrowhead DB), dorsal trunk (arrowhead DT), lateral trunk (arrowhead LT), and ganglionic branch (arrowhead GB). Atrial cells
and nervous system staining are indicated as in panel A. (C) Ventral view showing dys expression in the ganglionic branch fusion cells (arrowhead
GB) that later fuse to form the ventral anastomoses, and lateral trunk fusion cells (arrowhead LT). The ventral midline is indicated by an asterisk.
(D) Dorsal view of a stage 13 embryo hybridized in situ with dys antisense DIG RNA probe. Hybridization (arrowheads) was detected in the same
cell types as observed in panel A for Dys antibody staining. (E) Sagittal view of a stage 13 embryo hybridized to a dys antisense probe showing
hybridization to the same cell types that stained with anti-Dys in panel B. (F) Sagittal view of a stage 14 Df(3R)Espl3 homozygous mutant embryo
stained with -Dys. Df(3R)Espl3 is deleted of the dys gene. There is a complete absence of -Dys staining in all cell types, which confirms the
specificity of the -Dys staining. The parental strain contained a Kr-Gal4 UAS-GFP balancer chromosome, and Df(3R)Espl3 homozygous mutants
were selected based on their absence of GFP expression.
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ing visualizes tracheal development at all stages of development
(Fig. 6). Primary branches originate from tracheal precursor
cells at stage 11. At this time, Dys protein is undetectable. At
stage 12, before the tracheae fuse in the dorsal trunk, dys
expression is first detected. It remains on at high levels
throughout the remainder of embryonic development (to stage
17) in the dorsal trunk. Lateral trunk cells fuse later (stage 15)
than the dorsal trunk, and dys expression correspondingly also
appears later in the lateral trunk (stage 13) than in the dorsal
trunk (stage 12) (Fig. 6). However, dys expression in the lateral
trunk still precedes its fusion. The dorsal branches and gangli-
onic branches fuse later (stages 16 to 17) than the lateral trunk
and dorsal trunk (data not shown), and dys expression also
appears later (stage 14) than in the dorsal trunk and lateral
trunk. Thus, Dys protein appears before fusion of each branch,
and its appearance in each branch type correlates with the
timing of branch fusion.
Dys colocalizes with nuclear Tgo in vivo. Since Tgo is nu-
clear only in the presence of a partner bHLH-PAS protein, if
Dys and Tgo dimerize in vivo, Tgo should be found in nuclei of
Dys-positive cells. Embryos were double stained for Dys and
Tgo (Fig. 7). Most relevant are the leading-edge cells, since no
other bHLH-PAS proteins are known to be expressed in these
cells. Strong Tgo nuclear localization was observed that over-
laps exactly with Dys (Fig. 7A and B). Tracheal fusion cells
were also examined for nuclear Tgo levels. Examination of
fusion cells of all four types of branches indicated high levels of
nuclear Tgo accumulation colocalizing with Dys nuclear local-
ization (Fig. 7C to H). These results are consistent with Tgo
being a partner for Dys in vivo, although the presence of Trh
in tracheal fusion cells could also contribute to Tgo nuclear
localization (but see below). Of particular note is the finding
that, qualitatively, the levels of nuclear Tgo appear constant in
fusion cells throughout development, both before and after the
appearance of Dys.
Injection of dys-dsRNA results in tracheal fusion defects.
The relationship between dys expression and tracheal fusion
branches suggests a role of dys in tracheal fusion events. Mu-
tants of dys are not available, so dys-RNAi was utilized to test
function. dys-dsRNA was injected into embryos, and tracheal
development was assessed. Negative controls included em-
bryos injected with TE and GFP-dsRNA. Staining of dys-
dsRNA-injected embryos with anti-Dys indicated that Dys pro-
tein was undetectable (Fig. 8A and B and 9). An indication that
dys is required for normal development is demonstrated by the
increased lethality of dys-dsRNA-injected embryos compared
to those injected with negative controls. 98% of the embryos
(n  200) injected with dys-dsRNA died before adulthood
compared to 48% injected with GFP-dsRNA (n  200). Both
samples had similar levels of embryos hatching into larvae:
66% of dys-dsRNA injected embryos hatched and 62% in-
jected with GFP-dsRNA hatched. Thus, dys is probably not
required for embryonic viability. The dys ds-RNA-injected em-
bryos that survived embryonic development died as second-
and third-instar larvae.
Since loss of dys function is lethal and dys is prominently
expressed in tracheal fusion cells, we examined dys-dsRNA-
injected embryos for defects in tracheal fusion. Injected em-
bryos were analyzed by (i) immunostaining with MAb 2A12,
which stains the tracheal lumen and outlines tracheal branches,
FIG. 4. dys is expressed in the leading-edge cells. A stage 14
pucA251.1F3 embryo that expresses P[lacZ] in the leading-edge cells is
shown. The embryo was double stained with anti-Dys (A; green) and
anti--Gal (C; red). A merged image is shown in panel B. Anterior is
to the left and dorsal is at the top. Colocalization of both Dys and
-Gal was observed in leading-edge cells.
FIG. 5. dys is expressed at sites of tracheal fusion. Whole-mount
stage 15 and 16 embryos were stained with anti-Dys (green) and MAb
2A12 (red), which stains the tracheal lumen. Two segments are shown
in panels A, B, and C; one segment is shown in panel D. Two Dys-
positive cells can be seen at sites of tracheal fusion (panel A, panel B,
and one segment of panel C), and one cell stained in each unfused
branch at sites that will soon undergo fusion (panel D and one segment
of panel C). Cells stained in all four types of tracheal fusion branches,
including the dorsal trunk (DT) (A), the lateral trunk (LT) (B), the
dorsal branch (DB) (C), and the ganglionic branch (GB) (D).
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and (ii) examination of larval tracheae by using bright-field
optics. The results showed a complete absence of lateral trunk,
dorsal branch, and ganglionic branch fusion in embryos in-
jected with dys-dsRNA. Embryos injected with TE or GFP-
dsRNA showed normal tracheal fusion. In wild-type embryos,
lateral trunk fusion occurs at stage 15 when the anterior lateral
trunk buds and posterior lateral trunk buds from adjacent
segments fuse (Fig. 8A and C) (24). Embryos at stage 15 or
older and larvae from dys-dsRNA-injected embryos do not
have fused lateral trunks (Fig. 8B and D). The frequency of
dys-dsRNA-injected embryos with lateral trunk defects was
92% (n  25). Each embryo with lateral trunk defects showed
a lack of lateral trunk tracheal fusion in all segments, indicating
that expressivity was at 100%. In contrast, every embryo in-
jected with TE or GFP-dsRNA (n  10 each) showed fused
lateral trunks in all segments. The specificity of the dys-RNAi
treatment was validated for several reasons: (i) the overall
embryonic morphology was normal, (ii) many embryos with
FIG. 6. Expression of dys during tracheal development. Images reveal the relative dynamics of Dys and Trh protein localization and esg
expression. Embryos that express lacZ in an esg pattern (esg05730 P[esg-lacZ]/TM3) were triple stained with --Gal (blue), -Dys (red), and -Trh
(green). Shown are five successive stages of dorsal trunk (DT) development and five successive stages of lateral trunk (LT) development. The stages
and tracheal branch type are indicated to the left of the images. The merge column shows triple staining, and the two -Trh column are different
magnifications of the same cells. Arrowheads indicate the location of selected tracheal fusion cells.
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tracheal fusion defects were healthy enough to hatch and sur-
vive until the second- and third-instar stages, (iii) tracheal
branching and morphology were generally normal (the only
gross defects were in fusion), and (iv) control embryos had
normal tracheal fusion, whereas dys-RNAi embryos showed a
high degree of fusion defects.
Examination of the larval dorsal and ganglionic branches in
dys-dsRNA-injected individuals showed a complete absence of
fusion (Fig. 8E to H). No segments were observed with fused
dorsal branch or ganglionic branches. Branching and migration
of the dorsal branch and the ganglionic branch were essentially
normal; only fusion defects were observed. Dorsal trunk fusion
appeared normal (Fig. 8I and J), even though dorsal trunk
fusion cells express dys, and Dys protein was absent in dys-
dsRNA-injected embryos. The lack of dorsal branch, lateral
trunk, and ganglionic branch fusion and the presence of dorsal
trunk fusion in dys-dsRNA-injected embryos roughly mimics
mutations in esg, which also affect dorsal branch, lateral trunk,
and ganglionic branch fusion but not dorsal trunk fusion (42,
46). It was not possible to confirm the dys-RNAi results genet-
ically, since analysis of the Df(3R)Espl3 dys deletion strain was
uninformative. Staining of Df(3R)Espl3 with anti-Trh and
MAb 2A12 showed only the rudiments of antibody-positive
staining, and these mutant embryos lack identifiable tracheae,
presumably due to the deletion of genes other than dys (data
not shown). Thus, fusion events could not be assayed.
Dys downregulates levels of Trh. trh is expressed in all tra-
cheal cells at the beginning of tracheal development and acts as
a master regulator of tracheal development. Trh proteins levels
remain high during tracheal development in most tracheal cells
(Fig. 6) (49). Since Tgo is the likely dimerization partner for
both Dys and Trh, and these proteins could, in principle, com-
pete for Tgo in the same cells, we examined whether Trh levels
remained constant in tracheal fusion cells in the presence of
high levels of Dys. Heterozygous esg05730 embryos expressing
esg-lacZ to mark fusion cells were stained for Dys, -Gal, and
Trh (Fig. 6). Before dys is expressed, Trh is at high levels in
fusion cells at equivalent levels to adjacent tracheal cells. As
Dys protein accumulates in the fusion cells, Trh levels decline
and remain low through the end of tracheal development. This
occurs in fusion cells in the dorsal trunk (Fig. 6), lateral trunk
(Fig. 6), dorsal branch (not shown), and ganglionic branch (not
shown). Examination of Dys-positive tracheal fusion cells (n 
82) indicated that 93% showed a marked reduction in Trh
levels compared to adjacent tracheal cells.
The requirement of dys in regulating Trh levels was exam-
ined by staining esg05730 esg-lacZ embryos injected with dys-
dsRNA for Trh in fusion cells (Fig. 9). Only heterozygous
embryos were examined. Tracheal fusion cells were identified
by staining for -Gal. Levels of -Gal in fusion cells were
comparable to control-injected embryos, indicating that esg
transcription is not substantially affected by the depletion of
Dys. Trh levels in Dys-depleted fusion cells were at high levels
comparable to the levels observed in adjacent tracheal cells.
Quantitatively, 96% of fusion cells examined in dys-dsRNA-
injected embryos showed high levels of Trh (n  23 cells). This
indicates that the reduction in Trh levels in fusion cells is
dependent on dys function.
The trh, tgo, and dfr genes encode a transcription factor
complex that is required for the development of tracheal cells
from dorsal ectoderm and, directly or indirectly, the expression
of most genes expressed in the trachea (4, 16, 50, 53). Appear-
ance of Trh protein precedes Dys by several hours (50). The
expression of dys was examined in a trh mutant background
and found to be absent (data not shown). Thus, trh is required
for dys expression, and Dys, in turn, modulates Trh levels.
Fusion cell levels of Dys are dependent on esg in all
branches except the dorsal trunk. Previous analysis of esg
FIG. 7. Dys and Tgo show nuclear colocalization. Embryos were
double stained with -Dys (green) and -Tgo (red). Sagittal views of
stage 14 (A to F, I, and J) and stage 15 (G and H) embryos are shown.
Images on the left show double-labeled merges (fusion cells in C, E, G,
and I are yellow), and the images on the right show only the -Tgo red
channel. Arrowheads indicate a Dys-positive cell for comparison be-
tween left and right images. (A and B) Leading-edge cells show nu-
clear accumulation of both Dys and Tgo. (C to J) Tracheal fusion cells
show nuclear colocalization with Tgo and that Tgo nuclear levels are
comparable to those of other tracheal cells. The tracheal branch type
is shown to the left of the images.
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mutants revealed that expression of fusion cell genes was af-
fected in some branches (dorsal branch and ganglionic branch)
but not others (dorsal trunk) (42, 46). In the dorsal branch and
the ganglionic branch, several fusion cell genes required esg
function, but others did not. Expression of dys follows esg
expression in all tracheal branches, raising the possibility that
its expression requires esg function. Multiple esg mutants were
analyzed, including the deletion strain esgG66 (Fig. 10). Anal-
ysis of esgG66 mutant embryos showed a complete absence of
dorsal branch and ganglionic branch dys expression in esg mu-
tant fusion cells. The lateral trunk also had no Dys-positive
cells but had some esg-lacZ-positive cells, a result consistent
with an earlier report that lateral trunk fusion cells die in esg
mutant embryos (42). Thus, it is difficult to assess whether esg
controls dys expression in the lateral trunk. In contrast, all
dorsal trunk fusion cells were Dys positive. The P-element
mutant, esg05730, showed a less severe phenotype. The dorsal
branch fusion cells were all Dys negative, and dorsal trunk
fusion cells were all Dys positive, as with the esgG66 mutant
embryos. However, there were occasionally esg-lacZ-positive
cells present in the defective, unfused lateral trunk branches;
some were Dys positive, and some were Dys negative. This was
also observed in esgG66, but only rarely. The ganglionic fusion
cells of esg05730 were also occasionally Dys positive. In sum-
mary, dys fusion cell expression requires esg in fusion cells of
the dorsal branch and ganglionic branch, and possibly the
lateral trunk, but not in the dorsal trunk.
DISCUSSION
Drosophila Dys is a member of a distinct bHLH-PAS sub-
family. Drosophila Dys belongs to a novel conserved subfamily
of bHLH-PAS proteins that includes C. elegans C15C8.2 and
H-NXF. Dys also likely belongs to an extended family of Dro-
sophila bHLH-PAS proteins, including Sim, Sima, Ss, and Trh,
that dimerize with Tgo. The protein structure of Dys is con-
ventional for bHLH-PAS proteins. The bHLH domain is near
the N terminus of the protein and is followed by the PAS-1 and
PAS-2 domains. One unusual feature compared to other
bHLH-PAS proteins is the relatively long (152 aa) region N-
terminal to the bHLH domain. This region has a large number
of glutamine residues and may act as a transcriptional activa-
tion domain. The C-terminal residues after the PAS-2 domain
are unconserved with C15C8.2, H-NXF, or any other protein
but have histidine-rich, proline-rich, and glutamine-rich re-
gions. These residues may also be transcriptional activation
domains. The structure of the Dys protein suggests a DNA-
FIG. 8. Removal of dys function by dys-RNAi reveals tracheal fu-
sion defects. Blastoderm embryos (w1118) were injected with either
GFP-dsRNA (negative control) or dys-dsRNA and assayed for tra-
cheal defects. (A) Stage 16 embryo injected with GFP-dsRNA and
stained with -Dys and MAb 2A12 that stains the tracheal lumen.
Prominently shown is the lateral trunk, which has fused. Arrows point
to lateral trunk Dys-positive fusion cells. The ganglionic branch (ar-
rowhead GB) and lateral branch G (arrowhead LG), which emanates
from the lateral trunk, are also indicated. (B) Stage 16 embryo injected
with dys-dsRNA and stained with -Dys and MAb 2A12. The embryo
showed a lack of lateral trunk fusion (the asterisk indicates the normal
location of a lateral-trunk fusion in wild-type or control embryos).
Ganglionic Branch (GB) and lateral branch a (LG) are noted by
arrowheads. No Dys-positive cells were observed, indicating that the
dys-RNA effectively abolished Dys protein. (C to J) Second-instar
larvae injected with either GFP-dsRNA or dys-dsRNA were examined
by bright-field microscopy for tracheal defects. Sites of fusion are
indicated by an arrow in control embryos. (C and D) Sagittal views
showing the lateral trunk with ganglionic branches and lateral branch
G. The dorsal trunk is also shown. The GFP-RNA larvae showed
normal lateral trunk fusion (arrow) (C), but the dys-RNA larval lateral
trunk failed to fuse (❋ ) (D). (E) Dorsal view showing the dorsal fusion
site (arrow) of two dorsal branches in the GFP-RNA larva. (F) The
dys-RNA dorsal branches migrate to the dorsal midline but fail to fuse
(❋ ). (G and H) Ventral view showing the sites of ventral anastomosis
of two pair of ganglionic branches. (G) In the GFP-RNA larva the
arrow indicates the fusion of the two ganglionic branches indicated by
arrowheads. (H) Fusion failed to occur (❋ ) in the dys-RNA larva. (I
and J) Dorsal view showing that the dorsal trunks are fused in both
GFP-RNA (I) and dys-RNA (J) larvae. The fusion site is indicated by
arrows, and the lateral trunk branch is also labeled.
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binding transcriptional activator, but this needs to be tested
biochemically.
dys is expressed in a variety of embryonic cell types. Dro-
sophila dys is expressed in a variety of embryonic cell types,
including tracheal fusion, leading edge, foregut atrium, brain
or stomagastric nervous system, hindgut, and anal pad cells.
Initial expression was observed during mid embryogenesis at
stage 12. The function of dys in these cell types is unknown,
with the exception of the tracheal fusion cells, in which we
showed that dys plays a developmental role. The dys-RNAi
results showed that dys is an essential gene. However, dys-
dsRNA-injected embryos did not die as embryos, but as sec-
ond- and third-instar larvae. Thus, the role of dys, as assayed by
RNAi, in the various embryonic cell types is not dramatic
enough to cause embryonic lethality. Mutations in esg show
fusion defects in the same tracheal branches as dys and are also
lethal to larvae. The tracheal fusion defects and resulting pu-
tative respiratory deficiencies may be the cause of the larval
lethality, since other observations have shown that animals
with defective tracheae survive until late larval periods (24).
However, both genes are expressed elsewhere, and defects in
the other cell types may contribute to lethality.
dys is required for tracheal fusion. dys is expressed in tra-
cheal fusion cells, and no other tracheal cells. This was shown
by coexpression of dys with esg, a gene that is expressed in
fusion cells and regulates tracheal fusion. dys-RNAi experi-
ments were carried out to examine whether dys is involved in
tracheal fusion. The results demonstrated that dys was re-
quired for fusion of the dorsal branch, lateral trunk, and gan-
glionic branch but not of the dorsal trunk. This phenotype was
similar to the esg mutant phenotype that also affected the
dorsal branch, lateral trunk, and ganglionic branch but not the
dorsal trunk. Although branches differ in the details of the
fusion process, tracheal fusion generally requires migration,
recognition, and adhesion of fusion cells. dys-RNAi embryos
showed relatively normal tracheal branches and migration. The
occurrence of a single esg-lacZ cell in each dys-RNAi branch
indicated that esg-positive tracheal fusion cells were present,
and thus survival and gross cell fate is not controlled by dys. It
is possible that dys controls aspects of fusion cell recognition,
cell adhesion, or inhibition of nonfusion tracheal functions,
such as branching.
Since dys, as well as esg, is expressed in dorsal trunk fusion
cells, why is dorsal trunk fusion apparently unaffected in dys-
RNAi-injected embryos? It is not likely due to incomplete
expressivity of the dys-RNAi, since we were not able to detect
Dys protein in dys-RNAi-injected embryos, including dorsal
trunk fusion cells, and 	100% of lateral trunk, dorsal branch,
and ganglionic branch branches in dys-dsRNA-injected em-
bryos failed to fuse. As discussed previously (46), there are a
number of differences between the dorsal trunk and the other
branches that could contribute to differences in fusion behav-
FIG. 9. dys-dsRNA-injected embryos show increased levels of Trh
in fusion cells. Embryos from esg05730 P[esg-lacZ]/CyO P[ftz-lacZ] par-
ents were injected with dys-dsRNA and immunostained with --Gal
(esg-lacZ and ftz-lacZ) (blue), -Dys (red), and -Trh (green). Only
heterozygous embryos were analyzed. Dorsal trunks at stages 14 and
17 are shown. Arrowheads indicate selected fusion cells. esg-lacZ is
expressed at comparable levels in dys-dsRNA-injected embryos com-
pared to wild-type or GFP-dsRNA (control)-injected embryos (see
Fig. 6). Staining with -Dys shows an absence of Dys protein. The Trh
levels in fusion cells are significantly higher than in wild-type or con-
trol-injected embryos (see Fig. 6) and are comparable to the levels in
adjacent tracheal cells. The two -Trh rows are higher magnifications
of the same embryo.
FIG. 10. dys fusion cell expression requires esg function in some
tracheal branches. Anterior is to the left. Arrowheads indicate fusion
cells. Fusion cell gene expression was examined in esgG66 mutant em-
bryos, which express esg-lacZ. Stage 15 embryos were stained with
--Gal and -Dys. Merge images are shown on the left. The dorsal
branch (DB) has esg-lacZ-positive fusion cells, but there is no Dys
protein present. The dorsal trunk (DT) fusion cells express both esg-
lacZ and dys. Occasionally, esgG66 mutant embryos had a reduced
number of dorsal trunk fusion cells. The ganglionic branch (GB) has
esg-lacZ-positive fusion cells, but Dys protein is absent. Most lateral
trunk (LT) fusion cells are absent due to cell death (42), and there are
no esg-lacZ or Dys-positive cells present. The arrows indicate sites in
which fusion cells are located in wild-type lateral trunks. esg-lacZ-
positive cells that are not fusion cells are indicated by an asterisk.
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ior. The larger diameter dorsal trunk has multiple cells com-
prising its circumference, unlike most of the other branches,
which are thinner and have a single cell comprising the cir-
cumference. Dorsal trunk branches are in close proximity to
their fusion partner and lack the filopodial extensions that help
guide the other branches to their targets. The dorsal trunk also
utilizes a mesodermal guidepost cell that mediates fusion (51).
Similar guidepost cells have not been described for the other
branches. Finally, breathless RNA levels begin to decline by
stage 12 in the dorsal trunk due to spalt repression (31), which
may eliminate the potential need to reduce breathless levels by
decreasing Trh levels. These and other possible differences
suggest why dys and esg may have different functions in differ-
ent branches.
The esg gene is required in dorsal branch and ganglionic
branch tracheal fusion cells for expression of several genes,
including shotgun (DE-cadherin) and three late-expressing fu-
sion cell genes (fusion-4 to fusion-6), as well as repression of
terminal branching genes (DSRF and terminal-1) (42, 46). Ex-
pression of two early-expressing fusion cell genes (fusion-2 and
fusion-3) are not dependent on esg. dys expression is also de-
pendent on esg, in keeping with the role of esg in regulating
early-expressing fusion cell gene expression. As with other
genes expressed in fusion cells, dys expression was not depen-
dent on esg in dorsal trunk cells. This implies that the ability of
esg to activate transcription is fusion cell dependent and is due
to the presence of different coregulatory proteins or modifier
proteins in the different branches.
Cross-regulatory interactions among bHLH-PAS proteins.
The trh gene is required for initiation of tracheal formation. trh
expression is maintained throughout embryonic development
in most tracheal cells, and this continued expression is due to
autoregulation (50). However, the role of trh beyond its role in
initiating tracheal formation is not well understood. We have
shown that Trh protein levels fall specifically in all classes of
tracheal fusion cells coincident with the rise in Dys levels. The
nuclear levels of Tgo, the partner for both Dys and Trh, remain
constant in fusion cells. The biological significance of the re-
duction in Trh remains to be investigated, but it is possible that
fusion requires a reduction in Trh. One possibility is that Trh:
Tgo is required for the expression or function of the breathless
(btl) tyrosine kinase receptor that guides growing tracheal
branches (31) and that btl function must be inhibited in fusion
cells. Potentially, the only function of dys is to reduce Trh
levels.
There are multiple mechanisms in which Dys could regulate
Trh levels. These mechanisms include (i) competition between
Dys and Trh for dimerization with Tgo, (ii) competitive Dys:
Tgo binding to Trh:Tgo autoregulatory binding sites in the trh
gene, (iii) activation of genes by Dys that encode proteins
influencing trh RNA or protein stability, and (iv) inhibition of
protein kinase B that is required for Trh nuclear transport
(19). Conceptually, the first model is the simplest and most
attractive. Trh autoregulates its own expression (50), and re-
duction in Trh:Tgo complexes by competition for Tgo by Dys
would lead to a reduction in trh RNA and protein. In the
second model, Dys:Tgo would function as a transcriptional
repressor and extinguish trh RNA synthesis by binding Trh:Tgo
autoregulatory sequences within the trh gene.
Evidence for the possible roles of these mechanisms has
emerged from studies on vertebrate and Drosophila bHLH-
PAS proteins. In one study (13), it was demonstrated that
HIF-1 outcompetes the Aryl hydrocarbon receptor (Ahr)
bHLH-PAS protein for their common dimerization partner,
Arnt, which is the vertebrate Tgo ortholog. In another study
(52), Sim2 was shown to compete with HIF-1 for Arnt and
partially block expression of a HIF-1:Arnt responsive re-
porter gene. Sim2 can repress transcription and, by binding to
HIF-1:Arnt recognition sites on the reporter gene, it reduced
its expression. The third model in which the presence of Dys
reduces protein levels by activating the transcription of repres-
sive or inhibitory factors is analogous to how Sim:Tgo re-
presses the expression of genes in the central nervous system
midline cells by activating transcription of a repressor (10).
One additional issue is whether Dys reduces the levels of
Drosophila bHLH-PAS proteins besides Trh. One possibility is
Sim. Both Sim and Dys are expressed in anal pad cells (36),
and sim mutants have anal pad defects (26, 36).
Evolution of bHLH-PAS proteins. Drosophila has four
bHLH-PAS proteins that dimerize with Tgo: Sim, Sima, Ss,
and Trh. Dys is also likely to dimerize with Tgo. One particu-
larly interesting observation is that Drosophila Dys, Trh, and
Sima are all involved in aspects of tracheal development.
Mammals have closely related members of all of these proteins
(Fig. 2). The mammalian proteins dimerize with either Arnt or
the closely related Arnt2. C. elegans has four bHLH-PAS part-
ners for AHA-1, the worm Tgo/Arnt ortholog. These partners
include (i) C15C8.2, which is related to Dys and mammalian
NXF; (ii) AHR-1, which is related to Drosophila Ss and ver-
tebrate Ahr; (iii) HIF-1, which is related to Drosophila Sima
and vertebrate HIF-1; and (iv) T01D3.2, which is related to
Sim and Trh. Since orthologs of Dys, Ss, Sima, and Sim/Trh are
found in vertebrates, insects, and nematodes, these proteins
had already diverged in the common ancestor of these species.
The C. elegans C15C8.2 gene is expressed in the pharynx, a
feeding organ (Powell-Coffman, unpublished). The mamma-
lian dys gene, NXF, has been detected only in the brain (Patter-
son, unpublished). The evolutionary conservation of the Dys
subfamily of proteins suggests a functional relationship, al-
though the sites of expression in Drosophila and the other
organisms, as studied to date, are diverse. One possibility
based on the tracheal fusion phenotypes is that Dys regulates
aspects of cell recognition or cell adhesion events. It will be
interesting to determine in future studies what biochemical,
developmental, or physiological features of the Dys proteins
are conserved, as well as the evolutionary origins regarding the
tracheal functions of Dys, Sima, and Trh.
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